Roche records 4% decline in H1 2024 net income
Sales for the first half of the year rose by 5% CER, driven by demand for medicines and diagnostics.
Drug Development
Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn
AbbVie’s Q2 2024 net earnings drop to $1.37bn
AC Immune wins FDA fast track for Alzheimer’s vaccine
FDA agrees wider use of BioMarin’s BRINEURA for CLN2
NICE recommends Boehringer’s tenecteplase for NHS stroke care
Dren Bio and Novartis link on bispecific antibodies for cancer
MHRA approves Pfizer-BioNTech’s Comirnaty JN.1 vaccine
